Home / Generic medicine
Generic medicine

Sofosbuvir + Velpatasvir

Sofosbuvir + Velpatasvir · ATC J05AP · Anti-infectives · Antivirals

Data statusRegistration & price fields require source verification.
24brand families
29registered presentations
20companies
27with current prices
Available dosage forms

Choose a form

Tap a form to filter the brand list
Tablet29 products
Advertisement · clearly labelled sponsored placement
Pakistan brand index

Available brands

One brand is shown once per manufacturer; strengths, forms, packs and DRAP registrations remain visible as separate presentations.
Print / Save PDFAll 29 presentations
ShareSend this page
24 brands · 29 presentations
Reset
BrandManufacturerRegistered presentations
ABRIVA PLUS1 presentation CCL Pharmaceuticals (Pvt.) Limited
400 mg + 100 mg Tablet 28's 091781 PKR 19,821.252026-07-23 PKR 707.90/ tablet
Bosovel1 presentation Bosch Pharmaceuticals (Pvt) Ltd.
400 mg + 100 mg Tablet 28's 094785 PKR 19,415.002026-07-27 PKR 693.39/ tablet
Cure-C Forte1 presentation Global Pharmaceuticals (Pvt.) Ltd.
400 mg + 100 mg Tablet 28's 097677 PKR 12,392.202026-07-27 PKR 442.58/ tablet
Dowvir1 presentation Martin Dow Limited
400 mg + 100 mg Tablet 28's 092860 PKR 19,821.262026-07-22 PKR 707.90/ tablet
Epclusa2 presentations Ferozsons Laboratories Limited
100 mg + 400 mg Tablet 28's 088368 PKR 72,137.002026-07-22 PKR 2,576.32/ tablet
100 mg + 400 mg Tablet 28's (patient) 088368 PKR 61,317.232026-07-22 —
Fosbu1 presentation Highnoon Laboratories Ltd
400 mg + 100 mg Tablet 14 099827 PKR 7,557.782026-07-27 PKR 539.84/ tablet
Fosbu V1 presentation Highnoon Laboratories Ltd
400 mg + 100 mg Tablet 28 099827 PKR 16,057.262026-07-27 PKR 573.47/ tablet
Fosbu V 4001 presentation Highnoon Laboratories Ltd
100 mg + 100 mg Tablet 14 099827 PKR 7,557.782026-07-27 PKR 539.84/ tablet
Hepgard-V1 presentation Barrett Hodgson Pakistan (Pvt.) Ltd
400 mg + 100 mg Tablet 28's 096188 PKR 17,235.872026-07-27 PKR 615.57/ tablet
HILVEL 400mg1 presentation Hilton Pharma (Pvt) Limited.
400 mg + 100 mg Tablet 28's 086973 PKR 20,364.342026-07-22 PKR 727.30/ tablet
Maclusa1 presentation Macter International Limited
400 mg + 100 mg Tablet 28's 086972 PKR 20,176.072026-07-23 PKR 720.57/ tablet
OCVIR-V1 presentation SAMI Pharmaceuticals Pvt. Ltd.
400 mg + 100 mg Tablet 28's 089075 PKR 19,947.372026-07-23 PKR 712.41/ tablet
Sofonil Plus1 presentation NovaMed Pharmaceuticals(Pvt.)Ltd
400 mg + 100 mg Tablet 14's 102380 PKR 8,028.632026-07-23 PKR 573.47/ tablet
Sovela1 presentation The Searle Company Limited
400 mg + 100 mg Tablet 28’s 090783 PKR 19,414.642026-07-23 PKR 693.38/ tablet
Velpaget1 presentation Getz Pharma (Pvt) Limited
400 mg + 100 mg Tablet 28's 086970 PKR 20,598.232026-07-27 PKR 735.65/ tablet
Velso1 presentation M/s. Genix Pharma (Pvt) Ltd.
400 mg + 100 mg Tablet 14's 086971 PKR 10,299.112026-07-23 PKR 735.65/ tablet
Velso 400mg2 presentations M/s. Genix Pharma (Pvt) Ltd.
400 mg + 100 mg Tablet 28's 086971 PKR 20,598.252026-07-23 PKR 735.65/ tablet
400 mg + 100 mg Tablet 7's 086971 PKR 5,149.562026-07-23 PKR 735.65/ tablet
VELSOVIR1 presentation Atco Laboratories Limited
100 mg + 400 mg Tablet 14s 089076 PKR 9,232.932026-07-23 PKR 659.50/ tablet
Vesoft3 presentations HIGH-Q Pharmaceuticals
400 mg + 100 mg Tablet 14's 092795 PKR 9,814.292025-08-18 PKR 701.02/ tablet
400 mg + 100 mg Tablet 28's 092795 PKR 19,628.592025-08-18 PKR 701.02/ tablet
400 mg + 100 mg Tablet 7's 092795 PKR 4,907.152025-08-18 PKR 701.02/ tablet
VIBRENTA-VPT 400mg1 presentation TABROS PHARMA (PVT). LTD.
400 mg + 100 mg Tablet 28'S 089071 PKR 19,945.062026-07-27 PKR 712.32/ tablet
Price movement

Official price changes for Sofosbuvir + Velpatasvir

1 official price change across 27 tracked presentations since 18 Aug 2025; median change +4.9%; largest +4.9% (Werya 400 mg + 100 mg)

Each dot is one DRAP-notified price change for one pack. Amber: increase; teal: decrease. Hover or tap for detail; click to open the brand.

BrandPackEffectiveOld to newChange
Werya 400 mg + 100 mg14's17 Aug 2026PKR 8,798.29 to 9,232.93+4.9%
Independent editorial layer

Medicine information

Clinical monographs should be independently written, referenced and medically reviewed. Product listings and advertisements must not determine clinical conclusions.

Cite this record

Molecule record · ATC J05AP
MedInfoBase. (2026). Sofosbuvir + Velpatasvir — registered brands and price distribution in Pakistan [Data set]. MedInfoBase. Retrieved September 24, 2026, from https://medinfobase.com/generic/sofosbuvir-velpatasvir/ ATC J05AP.
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.